Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

ALYSSA-MEDICA : revenue, balance sheet and financial ratios

ALYSSA-MEDICA is a French company founded 23 years ago, specialized in the sector Activités des voyagistes. Based in FORT-DE-FRANCE (97200), this company of category PME shows in 2018 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ALYSSA-MEDICA (SIREN 442620530)
Indicator 2024 2023 2022 2020 2018
Revenue N/C N/C N/C N/C 1 118 016 €
Net income 165 689 € 95 432 € 219 226 € -70 887 € 69 181 €
EBITDA N/C N/C N/C -76 266 € 123 487 €
Net margin N/C N/C N/C N/C 6.2%

Revenue and income statement

In 2024, ALYSSA-MEDICA generates positive net income of 166 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 69 k€ -> 166 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

165 689 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.194%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

26.699%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

41.9%

Solvency indicators evolution
ALYSSA-MEDICA

Sector positioning

Debt ratio
1.19 2024
2022
2023
2024
Q1: 0.23
Med: 15.32
Q3: 48.72
Good

In 2024, the debt ratio of ALYSSA-MEDICA (1.19) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
26.7% 2024
2022
2023
2024
Q1: 10.38%
Med: 23.42%
Q3: 39.82%
Good

In 2024, the financial autonomy of ALYSSA-MEDICA (26.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 341.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

341.342

Liquidity indicators evolution
ALYSSA-MEDICA

Sector positioning

Liquidity ratio
341.34 2024
2022
2023
2024
Q1: 118.69
Med: 170.44
Q3: 326.5
Excellent

In 2024, the liquidity ratio of ALYSSA-MEDICA (341.34) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
ALYSSA-MEDICA

Positioning of ALYSSA-MEDICA in its sector

Comparison with sector Activités des voyagistes

Valuation estimate

Based on 68 transactions of similar company sales (all years), the value of ALYSSA-MEDICA is estimated at 84 736 € (range 43 557€ - 318 309€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
68 tx
43k€ 84k€ 318k€
84 736 € Range: 43 557€ - 318 309€
NAF 5 all-time

Valuation method used

Net Income Multiple
165 689 € × 0.5x = 84 736 €
Range: 43 557€ - 318 310€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 68 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des voyagistes)

Compare ALYSSA-MEDICA with other companies in the same sector:

Frequently asked questions about ALYSSA-MEDICA

What is the revenue of ALYSSA-MEDICA ?

The revenue of ALYSSA-MEDICA in 2018 is 1.1 M€.

Is ALYSSA-MEDICA profitable?

Yes, ALYSSA-MEDICA generated a net profit of 166 k€ in 2024.

Where is the headquarters of ALYSSA-MEDICA ?

The headquarters of ALYSSA-MEDICA is located in FORT-DE-FRANCE (97200), in the department Martinique.

Where to find the tax return of ALYSSA-MEDICA ?

The tax return of ALYSSA-MEDICA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ALYSSA-MEDICA operate?

ALYSSA-MEDICA operates in the sector Activités des voyagistes (NAF code 79.12Z). See the 'Sector positioning' section above to compare the company with its competitors.